Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Infect Dis ; 14: 146, 2014 Mar 19.
Article in English | MEDLINE | ID: mdl-24645982

ABSTRACT

BACKGROUND: The aim of this study was to evaluate diagnostic tests in order to introduce a diagnostic strategy to identify the most common gram-positive bacteria (pneumococci, enterococci, ß-haemolytic streptococci and S. aureus) found in blood cultures within 6 hours after signalling growth. METHODS: The tube coagulase test was optimized and several latex agglutination tests were compared and evaluated before a validation period of 11 months was performed on consecutive positive blood culture patient samples from Kalmar County Hospital, Sweden. RESULTS: During the validation period 150 (91%) of a total of 166 gram-positive cocci (119 in clusters, 45 in chains or pairs and 2 undefined morphology) were correctly identified as S. aureus, CoNS, Pneumococci, Enterococci or group A streptococci (GAS), group B streptococci (GBS), group G streptococci (GGS) within 6 hours with a minimal increase in work-load and costs. The remaining samples (9%) were correctly identified during the next day. No samples were incorrectly grouped with this diagnostic strategy and no patient came to risk by early reporting. CONCLUSION: A simple strategy gives reliable and cost-effective reporting of >90% of the most common gram-positive cocci within 6 hours after a blood cultures become positive. The high specificity of the tests used makes preliminary reports reliable. The reports can be used to indicate the focus of infection and not the least, support faster administration of proper antimicrobial treatment for patients with serious bacterial infections.


Subject(s)
Bacteremia/microbiology , Bacterial Typing Techniques/methods , Gram-Positive Bacteria/classification , Gram-Positive Bacterial Infections/microbiology , Animals , Bacteremia/blood , Bacteremia/diagnosis , Gram-Positive Bacteria/isolation & purification , Gram-Positive Bacterial Infections/blood , Gram-Positive Bacterial Infections/diagnosis , Horses , Humans , Latex Fixation Tests , Rabbits , Reproducibility of Results , Sensitivity and Specificity , Sweden
2.
J Biol Chem ; 284(34): 22926-37, 2009 Aug 21.
Article in English | MEDLINE | ID: mdl-19520847

ABSTRACT

Amrinone is a bipyridine compound with characteristic effects on the force-velocity relationship of fast skeletal muscle, including a reduction in the maximum shortening velocity and increased maximum isometric force. Here we performed experiments to elucidate the molecular mechanisms for these effects, with the additional aim to gain insight into the molecular mechanisms underlying the force-velocity relationship. In vitro motility assays established that amrinone reduces the sliding velocity of heavy meromyosin-propelled actin filaments by 30% at different ionic strengths of the assay solution. Stopped-flow studies of myofibrils, heavy meromyosin and myosin subfragment 1, showed that the effects on sliding speed were not because of a reduced rate of ATP-induced actomyosin dissociation because the rate of this process was increased by amrinone. Moreover, optical tweezers studies could not detect any amrinone-induced changes in the working stroke length. In contrast, the ADP affinity of acto-heavy meromyosin was increased about 2-fold by 1 mm amrinone. Similar effects were not observed for acto-subfragment 1. Together with the other findings, this suggests that the amrinone-induced reduction in sliding velocity is attributed to inhibition of a strain-dependent ADP release step. Modeling results show that such an effect may account for the amrinone-induced changes of the force-velocity relationship. The data emphasize the importance of the rate of a strain-dependent ADP release step in influencing the maximum sliding velocity in fast skeletal muscle. The data also lead us to discuss the possible importance of cooperative interactions between the two myosin heads in muscle contraction.


Subject(s)
Actomyosin/metabolism , Adenosine Diphosphate/metabolism , Amrinone/pharmacology , Calcium Channel Blockers/pharmacology , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Amrinone/chemistry , Animals , Calcium Channel Blockers/chemistry , In Vitro Techniques , Kinetics , Models, Biological , Molecular Structure , Muscle Contraction/drug effects , Myofibrils/drug effects , Myofibrils/metabolism , Myosin Subfragments/metabolism , Protein Binding/drug effects , Rabbits
SELECTION OF CITATIONS
SEARCH DETAIL
...